Algen Biotechnologies Inc

San Francisco, CA · Biotech · Private

Machine learning platform for drug target discovery that analyzes single-cell RNA expression data from CRISPRi screens to identify transcriptional vulnerabilities in MYCN-driven cancers

Grants
$350K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
19
3 granted · 16 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma$350,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1593INSILICOS——
1594FAIRBANKS PHARMACEUTICALS——
1595Resonate Industries Inc—$555K
1596Algen Biotechnologies Inc——
1597Novear Therapeutics LLC——
1598AVANT IMMUNOTHERAPEUTICS, INC.——
1599Reveal Pharmaceuticals, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 19
  • Certain Chemical Compositions And Methods Of Use Thereofgranted
  • Methods And Systems For Identifying Target Genesapplication
  • Methods And Systems For Determining Drug Effectivenessapplication
  • Methods And Systems For Identifying Target Genesgranted
  • Certain Chemical Compositions And Methods Of Use Thereofgranted
  • Methods And Systems For Identifying Target Genesapplication
  • Compositions And Methods For Treating Ras-mutant Cancersapplication
  • Methods And Systems For Determining Drug Effectivenessapplication
  • Methods And Systems For Identifying Target Genesapplication
  • Certain Chemical Compositions And Methods Of Use Thereofapplication
  • Compositions And Methods For Treating Ras-mutant Cancersapplication
  • Improved Methods And Compositions For Crispr Interference And Activationapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.